Stock Events

Stock Events

Quantum BioPharma 

€3.66
142
+€0.1+2.81% Thursday 06:05

Statistics

Day High
3.66
Day Low
3.66
52W High
14.3
52W Low
1.62
Volume
-
Avg. Volume
-
Mkt Cap
13.97M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

8MayExpected
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Next
-3.54
-2.38
-1.23
-0.07
Expected EPS
-0.77021718359256
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-27MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 0K91.F. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Cronos Group
CRON
Mkt Cap962.94M
Cronos Group is involved in the production and sale of cannabis and cannabis-derived products, making it a direct competitor in the cannabis market.
Tilray Brands
TLRY
Mkt Cap1.5B
Tilray is a global leader in cannabis research, cultivation, processing, and distribution, competing in the same market as FSD Pharma.
Canopy Growth
CGC
Mkt Cap418.51M
Canopy Growth Corporation operates in the cannabis and hemp business, directly competing with FSD Pharma in the cannabis industry.
Aurora Cannabis
ACB
Mkt Cap280.01M
Aurora Cannabis is engaged in the production, distribution, and sale of cannabis products, competing in the same industry as FSD Pharma.
Green Thumb Industries
GTBIF
Mkt Cap1.65B
Green Thumb Industries is involved in the cultivation, sale, and distribution of cannabis products, making it a competitor in the cannabis industry alongside FSD Pharma.

About

Quantum BioPharma Ltd., a biopharmaceutical company, researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company operates through two segments, Biopharmaceutical and Strategic Investments. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company is also developing a treatment for alcohol misuse for application in hospitals and other medical practices. In addition, it maintains a portfolio of strategic investments comprising loans secured by residential property. The company was formerly known as FSD Pharma Inc. and changed its name to Quantum BioPharma Ltd., in August 2024. Quantum BioPharma Ltd., is headquartered in Toronto, Canada.
Show more...
CEO
ISIN
CA74764Y2050
WKN
000A2P8F1

Listings

CN
CA
QNTM.CN
XNAS
US
QNTM
BOATS
BOATS
QNTM.BOATS
F
DE
0K91.F

0 Comments

Share your thoughts

FAQ

What is Quantum BioPharma stock price today?▼
The current price of 0K91.F is €3.66 EUR — it has increased by +2.81% in the past 24 hours. Watch Quantum BioPharma stock price performance more closely on the chart.
What is Quantum BioPharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Quantum BioPharma stocks are traded under the ticker 0K91.F.
Is Quantum BioPharma stock price growing?▼
0K91.F stock has risen by +15.82% compared to the previous week, the month change is a +27.97% rise, over the last year Quantum BioPharma has showed a +4.57% increase.
What is Quantum BioPharma market cap?▼
Today Quantum BioPharma has the market capitalization of 13.97M
When is the next Quantum BioPharma earnings date?▼
Quantum BioPharma is going to release the next earnings report on May 08, 2026.
What were Quantum BioPharma earnings last quarter?▼
0K91.F earnings for the last quarter are -1.09 EUR per share, whereas the estimation was -2.3 EUR resulting in a +52.49% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Quantum BioPharma revenue for the last year?▼
Quantum BioPharma revenue for the last year amounts to 0 EUR.
What is Quantum BioPharma net income for the last year?▼
0K91.F net income for the last year is -27M EUR.
When did Quantum BioPharma complete a stock split?▼
The last stock split for Quantum BioPharma was on October 27, 2025 with a ratio of 2:1.